Richard K. Cheng

发表

Risk of Cardiometabolic Risk Factors in Women With and Without a History of Breast Cancer: The Pathways Heart Study

C. Iribarren, Zaixing Shi, L. Kushi, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis: A Report of the American College of Cardiology Solution Set Oversight Committee.

M. Maurer, J. Clarke, M. Kittleson, 2023, Journal of the American College of Cardiology.

Outcomes of a drug shortage requiring switching in patients with ulcerative colitis

D. V. van Langenberg, M. Garg, Richard K. Cheng, 2020, World journal of gastrointestinal pathophysiology.

A validated risk stratification tool for detecting high‐risk small bowel Crohn's disease

G. Radford-Smith, K. Hanigan, J. Doecke, 2019, Alimentary pharmacology & therapeutics.

Long-Term Outcomes and Risk Stratification of Patients With Heart Failure With Recovered Ejection Fraction.

W. Levy, P. Mudigonda, Richard K Y Cheng, 2022, The American journal of cardiology.

Admission respiratory status predicts mortality in COVID‐19

N. Sotoodehnia, S. Gharib, B. McKnight, 2021, Influenza and other respiratory viruses.

Real-world Efficacy of Tafamidis in Patients with Transthyretin Amyloidosis and Heart Failure.

Kathleen W. Zhang, D. Lenihan, Joshua D. Mitchell, 2023, Current problems in cardiology.

ATTR Amyloidosis: Current and Emerging Management Strategies

M. Maurer, M. Grogan, J. Grodin, 2021, JACC. CardioOncology.

Trends in cardiovascular mortality of cancer patients in the US over two decades 1999‐2019

D. Fischman, A. Roguin, M. Graham, 2021, International journal of clinical practice.

Early Treatment of Cardiac ATTR

D. Lenihan, Richard K. Cheng, 2022, JACC. CardioOncology.

Combat Doxorubicin Cardiotoxicity With the Power of Mitochondria Transfer

D. Wang, R. Tian, Richard K. Cheng, 2021, JACC. CardioOncology.

Toward a More Precise Understanding of Obesity and Cancer and Cardiovascular Disease Risk

M. Simon, Richard K Y Cheng, K. Reding, 2022, JACC. CardioOncology.

Risk of heart failure with preserved versus reduced ejection fraction in women with breast cancer

C. Iribarren, L. Kushi, H. Greenlee, 2022, Breast Cancer Research and Treatment.

Letter: assessing iron deficiency in patients with IBD—a step in the right direction, but uncertainty remains

M. Garg, Richard K Y Cheng, Sheital Chand, 2020, Alimentary pharmacology & therapeutics.

Cardiotoxicity as an adverse effect of immunomodulatory drugs and proteasome inhibitors in multiple myeloma: A network meta‐analysis of randomized clinical trials

Y. Gong, B. Roy, Avash Das, 2021, Hematological oncology.

Frailty Among Patients With Acute ST-Elevation Myocardial Infarction in the United States: The Impact of the Primary Percutaneous Coronary Intervention on In-Hospital Outcomes.

I. Elgendy, E. Kontopantelis, P. Velagapudi, 2022, The Journal of invasive cardiology.